Endotoxins are lipopolysaccharides (LPS) found in the outer membrane of Gram-negative bacteria. These bacterial components are released during bacterial growth, cell death, or cell lysis and are among the most common contaminants in biological and pharmaceutical preparations.
Even at extremely low concentrations, endotoxins may trigger inflammatory immune responses, reduce cell viability, interfere with transfection efficiency, and compromise experimental reproducibility. Because endotoxins are highly heat-stable and biologically active, they are difficult to remove using standard sterilization procedures.
Endotoxin contamination may originate from water systems, laboratory equipment, purification workflows, raw materials, storage containers, or bacterial exposure during sample preparation and handling.
For peptides, oligonucleotides, proteins, biologics, and cell-culture reagents, endotoxin testing is often required to ensure experimental reproducibility, product safety, and regulatory compliance.
Endotoxins may trigger inflammatory immune responses even at very low concentrations and can significantly affect sensitive biological systems.
Endotoxins are heat-resistant, chemically stable, and difficult to eliminate without optimized depyrogenation workflows.
Endotoxin testing is commonly required for injectable materials, biologics, cell-culture reagents, and regulated pharmaceutical applications.
Bio-Synthesis offers both qualitative and quantitative endotoxin testing depending on your application, reporting requirements, and sensitivity needs.
The gel-clot assay is commonly used for qualitative endotoxin testing and pass/fail determination against a defined endotoxin limit.
The kinetic turbidimetric assay provides quantitative endotoxin analysis by monitoring turbidity changes during the LAL coagulation reaction.
Characterization of sample composition, buffer conditions, and endotoxin burden to determine the optimal removal strategy.
Application of validated depyrogenation chemistries and optimized cleanup workflows for peptides and oligonucleotides.
Pre- and post-removal endotoxin testing with documented analytical reporting and endotoxin reduction verification.
There is no single FDA endotoxin limit that applies to every peptide, oligonucleotide, protein, or biologic. The acceptable endotoxin level depends on the product type, route of administration, maximum dose, intended use, and regulatory requirements.
For injectable and parenteral products, endotoxin limits are commonly established using USP <85> and FDA bacterial endotoxin testing principles. The limit is typically calculated using:
Endotoxin Limit = K / M
K = threshold pyrogenic dose of endotoxin per kilogram of body weight. M = maximum product dose administered per kilogram of body weight per hour.
Commonly referenced K values include 5 EU/kg for most parenteral products and 0.2 EU/kg for intrathecal applications. Because the final limit depends on dose and route of administration, endotoxin specifications should be defined on a project-specific basis.
Bio-Synthesis can perform endotoxin testing and reporting according to customer-defined acceptance criteria or project-specific regulatory requirements. For research-use peptides and oligonucleotides, customers often define endotoxin targets based on downstream use, such as cell culture, transfection, or in vivo studies.
Support for biologics, injectable formulations, peptides, oligonucleotides, and pharmaceutical development programs.
Endotoxin-free sample preparation for transfection, cell culture, and animal studies.
Endotoxin testing, depyrogenation workflows, and analytical reporting for regulated and non-regulated projects.
Proper sample preparation and handling are important for accurate bacterial endotoxin testing. To minimize contamination risk and ensure reliable results, please review the following submission guidelines prior to shipping samples to Bio-Synthesis.
Certain buffers, detergents, solvents, salts, or highly concentrated biological materials may interfere with LAL assay performance. Bio-Synthesis may recommend dilution optimization or sample pretreatment when necessary.
Proteins, peptides, oligonucleotides, biologics, buffers, pharmaceutical preparations, and related biological samples may be evaluated.
Typical turnaround is 3–5 business days for endotoxin testing and 7–14 business days for full endotoxin removal projects.
Please provide sample concentration, buffer composition, molecule type, quantity, and any special handling requirements.
Acceptable endotoxin limits depend on the intended application, route of administration, and regulatory requirements. Research-use materials commonly target ≤0.5 EU/mg for cell culture applications and ≤0.1 EU/mg for in vivo studies, while injectable products typically follow USP <85> and FDA endotoxin calculation guidelines.
Yes. Even low endotoxin levels may reduce cell viability, alter immune responses, affect transfection efficiency, and compromise experimental reproducibility in sensitive cell-based assays.
Yes. Quantitative endotoxin analysis is available using kinetic turbidimetric LAL assay methodologies.
Bio-Synthesis offers complementary analytical services to support biologics, peptides, oligonucleotides, pharmaceutical materials, and research-grade samples.
Quantification and amino acid profiling for proteins, peptides, foods, supplements, and biological samples.
Microbial burden testing to assess contamination levels in raw materials, samples, and process-related materials.
Stability testing support for sample integrity, formulation performance, and time-dependent analytical evaluation.
LC-MS and MALDI mass spectrometry services for molecular weight confirmation, identity testing, and characterization.
Water content testing for peptides, oligonucleotides, biologics, and pharmaceutical materials.
Sodium content determination for analytical characterization, formulation support, and release documentation.
Contact Bio-Synthesis to discuss endotoxin testing, depyrogenation workflows, sample preparation, quantitative endotoxin analysis, or project-specific endotoxin requirements.
Trusted by biotech leaders worldwide for over 45+ years of delivering high quality, fast and scalable synthetic biology solutions.